Anti-Alzheimer's Disease Drugs (Cholinesterase Inhibitors, and NMDARA), and Anti-Parkinson's Disease Drugs (Dopaminergic Agents, and Dopamine Agonists) are Classified inside 2006 Global Strategic Business Report.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c45944) has announced the addition of Alzheimers and Parkinsons Disease - Global Strategic Business Report to their offering. This report analyzes the worldwide markets for Alzheimer's and Parkinson's Disease Parkinson's disease or Parkinsonism, degenerative brain disorder first described by the English surgeon James Parkinson in 1817. When there is no known cause, the disease usually appears after age 40 and is referred to as Parkinson's disease. in Millions of US$. The Major product classes Analyzed are Anti-Alzheimer's Disease Drugs (Cholinesterase Inhibitors, and NMDARA), and Anti-Parkinson's Disease Drugs (Dopaminergic dopaminergic /do·pa·min·er·gic/ (do?pah-men-er´jik) activated or transmitted by dopamine; pertaining to tissues or organs affected by dopamine. do·pa·mi·ner·gic adj. Agents, and Dopamine Agonists). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2010. The report profiles 72 companies including many key and niche players worldwide. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL URL in full Uniform Resource Locator Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. research and reported select online sources. Content Outline I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. Outlook 2. Neurodegenerative Diseases neurodegenerative diseases diseases characterized by neurodegeneration. Lesions are microscopic only but in chronic disease with massive involvement there may be grossly visible atrophy of affected nervous tissue. Market 3. Alzheimer's Market Overview 4. Parkinson's Disease Market Overview 5. Disease Overview 6. Drug Classification 7. Future Therapies 8. Recent Industry Activity 9. Focus on Select Players 10. Global Market Perspective III. MARKET 1. United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. 2. Canada 3. Japan 4. Europe 5. Rest of World IV. COMPETITION The Companies mentioned inside this report include: Amarin Corporation PLC (UK) Amorfix Life Sciences Ltd (Canada) Apotex, Inc (Canada) Asterand PLC (UK) Avicena Group, Inc (USA) Avigen, Inc (USA) Axonyx, Inc (USA) Boehringer Ingelheim GmbH (Germany) Boehringer Ingelheim Pharmaceuticals, Inc (USA) Boehringer Ingelheim (Egypt) Brainstorm Cell Therapeutics, Inc (USA) Bristol-Myers Squibb Company (USA) Bristol-Myers Squibb GmbH & Co KgaA (Germany): CeNeS Pharmaceuticals PLC (England) Cephalon Ceph´a`lon n. 1. (Zool.) The head. , Inc (USA) Ceregene, Inc (USA) Cita Neuropharmaceuticals, Inc (Canada) CMI (Computer-Managed Instruction) Using computers to organize and manage an instructional program for students. It helps create test materials, tracks the results and monitors student progress. India Pvt, Limited (India) Comtan (Canada) Desitin Arzneimittel GmbH (Germany) Draxis Health, Inc (Canada) Eisai Co, Ltd (Japan) Eisai, Inc (USA) Eli Lilly and Company Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical company and one of the world's largest corporations. Eli Lilly's global headquarters is located in Indianapolis, Indiana, in the United States. (USA) Eli Lilly and Company Limited (UK) Epix Pharmaceuticals (USA) Ester Neurosciences Ltd (Israel) Exelon (USA) F Hoffmann-La Roche Ltd (Switzerland) Forest Laboratories, Inc (USA) Forest Pharmaceuticals Inc (USA) Gerolymatos P N, SA (Greece) GlaxoSmithKline PLC (UK) GlaxoSmithkline NZ Ltd (New Zealand New Zealand (zē`lənd), island country (2005 est. pop. 4,035,000), 104,454 sq mi (270,534 sq km), in the S Pacific Ocean, over 1,000 mi (1,600 km) SE of Australia. The capital is Wellington; the largest city and leading port is Auckland. ) Glaxosmithkline SpA (Italy) H Lundbeck AS (Denmark) Lundbeck Espana SA (Spain) Impax Laboratories, Inc (USA) Johnson & Johnson (USA) Johnson & Johnson Pharmaceutical Research & Development LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control (USA) Janssen LP (USA) Kyowa Hakko Kogyo Co, Ltd (Japan) Medtronic, Inc (USA) Merck & Co, Inc (USA) Merz Pharmaceuticals GmbH (Germany) Mirapex (USA) Myriad Genetics, Inc (USA) Neuren Pharmaceuticals Limited (New Zealand) Neurim Pharmaceuticals () Ltd (Israel) Neurochem, Inc (Canada) Neurologix, Inc (USA) Newron Pharmaceuticals SpA (Italy) Novartis AG (Switzerland) Novartis Pharmaceuticals Corporation (USA) Novartis Deutschland GmbH (Germany) Novartis Pharma GmbH (Germany) NsGene A/S (Denmark) Nymox Pharmaceutical Corporation (Canada) Orion Corporation (Finland) Ortho-McNeil Neurologics, Inc (USA) Pfizer, Inc (USA) Pfizer Australia Pty, Ltd (Australia) Pfizer Manufacturing Belgium NV (Belgium) Pharmacopeia Drug Discovery Pharmacopeia Drug Discovery Inc is a US based corporation based in Princeton, New Jersey. They claim that they are trying to commercialize technologies to combinational chemistry. External links
Pharmaline Sal (Lebanon) ReGen Therapeutics PLC (UK) ReNeuron Ltd (UK) Richter Gedeon (Hungary) Samaritan Pharmaceuticals, Inc (USA) Sanofi-Aventis (France) Schering EspaEa SA (Spain) Sciele Pharma, Inc (USA) Senexis Limited (UK) Shire Pharmaceuticals Group PLC (UK) Somerset Pharmaceuticals, Inc (USA) Stalevo (USA) StemCells, Inc (USA) Terapia (Romania) Teva Pharmaceutical Industries Teva Pharmaceutical Industries Ltd. (Hebrew: טבע תעשיות פרמצבטיות בע"מ), NASDAQ: TEVA is an international pharmaceutical company headquartered in Ltd (Israel) Titan Pharmaceuticals, Inc (USA) TorreyPines Therapeutics (USA) Unipharm Ltd (Israel) Valeant Pharmaceuticals International Valeant Pharmaceuticals International is a pharmaceutical company with activities spanning the drug discovery pipeline from target identification through clinical trials and commercialization. (USA) Vernalis PLC (UK) Voyager Pharmaceutical Corporation (USA) Wyeth (USA) Zentiva AS Praha (Czech Republic) Zhejiang Yixin Pharmaceutical Company Limited (China) For more information visit http://www.researchandmarkets.com/reports/c45944 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion